| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0076-6879(95)51142-3 |
| P698 | PubMed publication ID | 7651220 |
| P2093 | author name string | N. Katunuma | |
| E. Kominami | |||
| P2860 | cites work | Participation of cathepsin B in processing of antigen presentation to MHC class II | Q70494348 |
| Different tissue distributions of two types of thiol proteinase inhibitors from rat liver and epidermis | Q70515975 | ||
| Inhibitions of degradation of rat liver aldolase and lactic dehydrogenase by N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl] agmatine or leupeptin in vivo | Q71232583 | ||
| Amino acid sequence of rat epidermal thiol proteinase inhibitor | Q71384662 | ||
| Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo | Q71479486 | ||
| Linkage between phosphorylated cystatin alpha and filaggrin by epidermal transglutaminase as a model of cornified envelope and inhibition of cathepsin L activity by cornified envelope and the conjugated cystatin alpha | Q72671264 | ||
| Mechanism and regulation of antigen processing by cathepsin B | Q72759147 | ||
| The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors | Q24300962 | ||
| The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity | Q27651464 | ||
| Characterization and amino acid sequence of a new acidic cysteine proteinase inhibitor (cystatin SA) structurally closely related to cystatin S, from human whole saliva | Q34179090 | ||
| Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization | Q39208753 | ||
| Purification and Properties of a New Cathepsin from Rat Liver1 | Q39222386 | ||
| Crystallization and Properties of Cathepsin B from Rat Liver | Q39292520 | ||
| Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining | Q40208923 | ||
| Phosphorylated cystatin alpha is a natural substrate of epidermal transglutaminase for formation of skin cornified envelope | Q43720679 | ||
| Molecular basis of intracellular regulation of thiol proteinase inhibitors | Q44571809 | ||
| The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins | Q45233152 | ||
| Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro | Q52477877 | ||
| Protein Inhibitors of Cysteine Proteinases. II. Primary Structure of Stefin, a Cytosolic Protein Inhibitor of Cysteine Proteinases from Human Polymorphonuclear Granulocytes | Q56706374 | ||
| Degradation of epidermal growth factor receptors by cathepsin L-like protease: inhibition of the degradation by c-Ha-ras gene products | Q68145334 | ||
| Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistation (EST) | Q68785348 | ||
| A new function of kininogens as thiol-proteinase inhibitors: inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens | Q70059595 | ||
| Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro | Q70136099 | ||
| Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo | Q70136102 | ||
| Total synthesis of the cystatin alpha gene and its expression in E. coli | Q70214501 | ||
| Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo | Q70402950 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 382-397 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives | |
| 37 Structure, properties, mechanisms, and assays ofcysteine protease inhibitors: Cystatins and E-64 derivatives | |||
| P478 | volume | 251 |
| Q73827911 | A novel procaspase-3 activating cascade in liver lysosomes, and lack of the cascade in hepatoma cells |
| Q36641648 | Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas |
| Q24672007 | CST3 genotype associated with exudative age related macular degeneration |
| Q22253211 | Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis |
| Q44988257 | Cysteine proteinase activity is required for survival of the parasite in experimental acute amoebic liver abscesses in hamsters. |
| Q46655566 | Differences in morphology of phagosomes and kinetics of acidification and degradation in phagosomes between the pathogenic Entamoeba histolytica and the non-pathogenic Entamoeba dispar |
| Q41644080 | Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells |
| Q46883140 | Dose-response inhibition of proteolytic activity by a cysteine protease inhibitor in a murine model of fasciolosis. |
| Q31444536 | Epoxysuccinyl peptide-derived affinity labels for cathepsin B. |
| Q28367246 | Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway |
| Q33935231 | Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates |
| Q58608856 | In Silico Study Reveals How E64 Approaches, Binds to, and Inhibits Falcipain-2 of Plasmodium falciparum that Causes Malaria in Humans |
| Q28541533 | Inhibition of cathepsin B by E-64 induces oxidative stress and apoptosis in filarial parasite |
| Q87421342 | Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway |
| Q43670726 | Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase |
| Q47714778 | Intracellular proteinases of invertebrates: calcium-dependent and proteasome/ubiquitin-dependent systems |
| Q44468632 | New cysteine protease inhibitors in physiological secretory fluids and their medical significance |
| Q77376182 | Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption |
| Q28198107 | Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis |
| Q48388158 | Purification and characterization of high molecular mass and low molecular mass cystatin from goat brain |
| Q40023816 | Requirements for proteolysis during apoptosis |
| Q73077056 | Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo |
| Q34598268 | Structure-based development of specific inhibitors for individual cathepsins and their medical applications |
| Q41856866 | Studies of inhibitory mechanisms of propeptide-like cysteine protease inhibitors |
| Q24543961 | The involvement of cysteine proteases and protease inhibitor genes in the regulation of programmed cell death in plants |
Search more.